Alaska Chapter of the American College of Cardiology

SYNCHRONIZE-1: GLP-1 Survodutide Led to Significant Weight Loss in Adults With Obesity
Survodutide led to significant weight loss in adults with obesity and without diabetes, according to results from the randomized, placebo-controlled SYNCHRONIZE-1 trial published June 7 in NEJM.
ACC Comments on 2027 IPPS Proposed Rule
The ACC submitted comments to the Centers for Medicare and Medicaid Services (CMS) regarding the fiscal year 2027 Inpatient Prospective Payment System (IPPS) proposed rule.
CLASP IID: Residual MR and Gradient at 1 Year Post M-TEER
Patients who underwent mitral transcatheter edge-to-edge repair (M-TEER) with an optimal result were more likely to have improved hemodynamics and less likely to experience major adverse events, all-cause mortality, heart failure (HF) hospitalization or reintervention at one year...
ACC CardiaCast: The Power of the Care Team
This episode provides a team-based overview of diagnosing and managing acute paroxysmal supraventricular tachycardia (PSVT) across care settings.
CKD Studies Spotlight GFR Measurement, Finerenone Benefit and Rivaroxaban Risk
Research presented at the European Renal Association Congress, held June 3-6 in Glasgow, Scotland, highlighted new findings in chronic kidney disease (CKD), including evidence supporting more precise GFR assessment and trial results on finerenone in nondiabetic CKD and rivaroxaban in advanced CKD patients with CV risk factors.